SERum-bank for PANcreatic Cancer

Summary

This study is about pancreatic cancer. If the diagnostic cancer is done at an early stage (\<2cm), the chances of recovery are very good. But the main problem is there is not any detections means for this cancer. Sadly, when there is a cancer diagnostic , it's already too late in the majority of cases, because the cancer is in an advanced case. Today, there is no any effective means of detection... Blood markers can be a simple means of early detection

Eligibility

ADENOCARCINOMA GROUP

Inclusion Criteria:

* Documented adenocarcinoma (cytology / anatomopathology), all stages, except if the tumor is immediately resectable and does not require preoperative cytological evidence. In this case, the inclusion and the first collection of the sero bank is done preoperatively. The diagnostic confirmation will therefore be made post-operatively at the risk of being excluded in the event of a different diagnosis.
* At the start of treatment (before surgery / 1st course of chemotherapy)
* Age ≥ 18 years
* Patient affiliated or entitled to a social security system

Exclusion Criteria:

* Patient refusal
* Acute renal failure
* Child-Pugh B or C cirrhosis
* Patient under guardianship or curators
* Other synchronous cancer or history of cancer \<5 years
* Language barrier

CONTROL GROUP

Inclusion Criteria:

* Age ≥ 40 years
* Patient affiliated or entitled to a social security system
* Digestive endoscopy for any reason other than cancer or chronic inflammatory bowel disease

Exclusion Criteria:

* Patient refusal
* Acute renal failure
* Child-Pugh B or C cirrhosis
* Patient under guardianship or curators
* Other synchronous cancer or history of cancer \<5 years

Conditions2

Interventions1

Related trials

• Angiogenic Biomarkers in Juvenile Idiopathic Arthritis — Assistance Publique - Hôpitaux de Paris
• Basal Plasma Lithium Levels and Suicidal Events — University Hospital, Montpellier
• Characterization of Natural Killer Cells in Severe Asthma Patients in Comparison With Control Subjects — Institut National de la Santé Et de la Recherche Médicale, France
• Clinical Study of the Hyperviscosity Syndrome in Waldenström Macroglobulinemia — Centre Hospitalier Universitaire, Amiens
• Combination of Alpelisib and Trametinib in Progressive Refractory Meningiomas — Assistance Publique Hopitaux De Marseille
• Comparison of Azathioprine to Methotrexate in Combination Therapy With Adalimumab in Crohn's Disease: an Open-label Randomized Controlled Trial — Centre Hospitalier Universitaire, Amiens
• Creation of a French South-Eastern Database and DNA-bank of Congenital Heart Disease to Explore the Genetic Pathways — Assistance Publique Hopitaux De Marseille
• Detection of ISUP≥2 Prostate Cancers Using Multiparametric MRI: Prospective Multicenter Comparison of the PI-RADS Score and an Artificial Intelligence System — Hospices Civils de Lyon

Browse More Trials